Lynparza Leads to Longer Survival in Men With Prostate Cancer

by admin_63069 | Mar 3, 2021 | News You Can Use

Lynparza demonstrates a significantly longer duration of survival compared Xtandi or Zytiga for men with metastatic prostate cancer, one study found.